Oral Semaglutide in Japanese Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials
Diabetes Obes Metab 2021 Oct 07;[EPub Ahead of Print], Y Yamada, D Yabe, CL Hertz, H Horio, J Nakamura, AM Nielsen, Y SeinoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.